Associate Professor, Harvard Medical School; Radiologist and Director, Institute for Innovation in Imaging, Massachusetts General Hospital

Charlestown Waterfront, Boston
Joined August 2019
Grand opening of the i3, with Dr. Dubach, Associate Director of the i3, discussing i3 services, facilities, and equipment. @JimBrinkMD @MGH_RI @MGHImaging
1
3
223
Grand opening of the i3, with Dr. Brink, Chief of MGB Enterprise Radiology, describing the founding of the i3. @MGHImaging @MGH_RI @JimBrinkMD
1
8
427
Grand opening of the i3, with Dr. Arnold, Executive Director of the CTRU, describing the collaboration between i3 and IBC to form the CTRU to provide translational clinical research services. @MGH_RI
1
2
183
Grand opening of the i3, with Dr. Caravan, Co-Director of the i3, giving examples of translational work and first-in-man studies. @JimBrinkMD @MGH_RI @MGHImaging @PeterCaravan
2
10
968
Grand opening of the i3, reception, with everyone having a great time. @MGH_RI @MGHImaging
2
5
416
Grand opening of the i3, with Dr. Chen, Co-Director of the i3, giving an overview of the i3. @MGHImaging @MGH_RI @JimBrinkMD @MGHChenLab
1
3
238
Grand opening of the i3, ribbon cutting, with Drs. Brink (center), Rosen (left), Weissleder (right), Caravan (far left), and Chen (far right). @JimBrinkMD @MGH_RI @MGHImaging @WeisslederLab @MGHCSB @MGHChenLab
1
2
2
31
5,832
MGH JWChen Lab retweeted
In this editorial, Dr. Chen discusses results from the article by Akai et al. on mouse model investigation of gadolinium brain deposition and behavioral testing, as well as the safety and medicolegal impact of these results. bit.ly/3gPgGss @MGHChenLab @HarvardMed
Administration of gadolinium-based contrast agents (GBCAs) in mice showed deposition in deep cerebellar nuclei with linear agents. Behavioral testing on these mice showed no effects on motor activity, anxiety, or memory. bit.ly/3mRFCDj #NeuroRad
1
5